Alkermes (ALKS) Gains from Investment Securities (2010 - 2026)

Alkermes (ALKS) reported Gains from Investment Securities of $1.8 million for Q1 2026, down 93.57% year-over-year from $28.8 million in Q1 2025, and up 107.27% quarter-over-quarter from -$25.5 million in Q4 2025.

Alkermes (ALKS) Gains from Investment Securities (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Gains from Investment Securities data on file, last reported at $1.8 million in Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at $1.8 million, down 93.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21.6 million (down 138.47% YoY), and the FY2025 annual result was $190358.0, down 98.91% from the prior year.
  • Gains from Investment Securities rose to $1.8 million in Q1 2026 per ALKS's latest filing, from -$25.5 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $28.8 million in Q1 2025 and troughed at -$25.5 million in Q4 2025.
  • A 5-year average of $5.3 million and a median of $2.2 million in 2024 frame the typical range for Gains from Investment Securities.
  • The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities jumped 8653.33% in 2022, then sank 3543.24% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $3.3 million in 2022, then jumped by 49.55% to $4.9 million in 2023, then soared by 403.4% to $24.8 million in 2024, then sank by 202.46% to -$25.5 million in 2025, then soared by 107.27% to $1.8 million in 2026.
  • Business Quant data shows ALKS's Gains from Investment Securities at $1.8 million in Q1 2026, -$25.5 million in Q4 2025, and $307000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.85 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 -25.46 Mn
Dec 31, 2025 -25.46 Mn
Sep 30, 2025 307,000.00
Sep 30, 2025 307,000.00
Jun 30, 2025 1.68 Mn
Jun 30, 2025 1.68 Mn
Mar 31, 2025 28.78 Mn
Mar 31, 2025 28.78 Mn
Dec 31, 2024 24.84 Mn
Dec 31, 2024 24.84 Mn
Sep 30, 2024 -24.21 Mn
Sep 30, 2024 -24.21 Mn
Jun 30, 2024 26.79 Mn
Jun 30, 2024 26.79 Mn
Mar 31, 2024 2.22 Mn
Mar 31, 2024 2.22 Mn
Dec 31, 2023 4.94 Mn
Dec 31, 2023 4.94 Mn